-

Twenty-Eight Lanier Law Firm Attorneys Named Among Nation’s Leading Litigators

Lawdragon list expands to include trial lawyers representing plaintiffs

HOUSTON--(BUSINESS WIRE)--A total of 28 attorneys from The Lanier Law Firm have been selected to the list of Lawdragon 500 Leading Litigators in America for 2027. This year marks the first time the publication has recognized a larger number of attorneys who primarily represent plaintiffs on the annual list, one of the company’s flagship legal guides.

“In the courtroom or at the negotiation table, we’re proud to be zealous advocates for those who have been harmed by the negligence of others, whether that’s an individual or one of the largest corporations in the world,” says firm founder Mark Lanier.

Share

The editors note this decision has greatly expanded the number of Leading Litigator honorees in an array of practices, including commercial litigation, product liability, personal injury, class actions, and disputes involving energy, technology and intellectual property.

“In the courtroom or at the negotiation table, we’re proud to be zealous advocates for those who have been harmed by the negligence of others, whether that’s an individual or one of the largest corporations in the world,” says firm founder Mark Lanier. “This latest recognition is a testament to the resources and reputation we bring to bear in every case.”

The firm’s Leading Litigator honorees and respective areas of expertise include:

Developed through more than 30 years of reporting on the legal profession, the Lawdragon selection process involves nominations and independent identification of top attorneys, extensive research, and reviews by panels of editorial advisors. The complete list of this year’s honorees is available here.

About The Lanier Law Firm
For more than 30 years, The Lanier Law Firm has represented clients nationwide in high-stakes litigation involving business disputes, mass torts, personal injury, defective products, asbestos exposure, and more. Named an Elite Trial Law Firm by The National Law Journal, the firm has offices in Houston, Fort Worth, New York, and Los Angeles. Learn more at www.lanierlawfirm.com.

Contacts

MEDIA CONTACT:
Kevin Roberts
713-659-5200
Media@lanierlawfirm.com

The Lanier Law Firm


Release Versions

Contacts

MEDIA CONTACT:
Kevin Roberts
713-659-5200
Media@lanierlawfirm.com

More News From The Lanier Law Firm

The Lanier Law Firm Named Mass Tort and Class Actions Law Firm of the Year

HOUSTON--(BUSINESS WIRE)--The Lanier Law Firm has earned the esteemed Law Firm of the Year award from Best Law Firms as the nation’s top legal practice for plaintiffs mass tort litigation and class actions. Along with this achievement, the firm retained its national honor in appellate practice. The firm’s offices in Houston, New York City and Los Angeles also earned placements in the guide for excellence across 10 practice areas. The Houston office earned Tier 1 rankings, the highest possible,...

Attorney Mark Lanier Calls for Social Media Companies to Make Meaningful Changes in Wake of Meta, Snap Settlements

LOS ANGELES--(BUSINESS WIRE)--While settlements have been reached with Meta Platforms Inc. and Snap Inc. in advance of the second bellwether trial over alleged addictive behaviors and mental health damages affecting young users of social media, lead trial attorney Mark Lanier says the companies must do more. "Families shouldn’t have to go jury by jury to solve a problem this big," says Mr. Lanier. "What these teenagers need is a permanent fix, real design changes that protect kids, not case-by-...

The Lanier Law Firm Supports Attorney General Ken Paxton in Reaching $45 Million Settlement with Gilead in Unlawful Inducement Scheme

HOUSTON--(BUSINESS WIRE)--Building on decades of holding pharmaceutical companies responsible for dangerous products and unlawful business practices, The Lanier Law Firm played a pivotal role supporting Texas Attorney General Ken Paxton in securing a $45 million settlement with Gilead Sciences, Inc. Announced on Oct. 22, the settlement resolves claims that the company offered illegal incentives to medical providers to prescribe its drugs over competitors’ medications. In many cases, these presc...
Back to Newsroom